Results 121 to 130 of about 6,307,860 (296)
BETA-2-AGONISTS and DEATH FROM ASTHMA
ESCOLA PAULISTA MED,DEPT PEDIAT,DIV ALLERGY CLIN IMMUNOL & RHEUMATOL,BR-04023 São Paulo,BRAZILDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Escola Paulista de Medicina, Sao Paulo, BrazilWeb of ...
Sole, Dirceu [UNIFESP] +2 more
core +1 more source
Posterior Disconnection Syndrome in Early‐Stage Adult‐Onset Cerebral Adrenoleukodystrophy
ABSTRACT Adult‐onset cerebral adrenoleukodystrophy is potentially treatable but often difficult to recognize before advanced cerebral involvement. Herein, we describe three men with early‐stage disease who initially presented with subtle visual complaints rather than subcortical dementia. Targeted neuropsychological testing revealed higher‐order visual
Kazuto Katsuse +13 more
wiley +1 more source
Clinical Immunology Communications: Inaugural Edition
Antonio La Cava
doaj +1 more source
Editorial to the Special Issue "Clinical Immunology in Italy, with Special Emphasis to Primary and Acquired Immunodeficiencies: A Commemorative Issue in Honor of Prof. Fernando Aiuti". [PDF]
Aiuti A, D'Amelio R, Quinti I, Rossi P.
europepmc +1 more source
Endothelial Cell Proteins as Biomarkers in Susac Syndrome
ABSTRACT Objective Susac syndrome (SS) is a rare CD8+ T cell–mediated microangiopathy affecting the brain, retina, and auditory labyrinth. Endothelial injury is thought to be a central mechanism; however, no circulating disease biomarkers are known. We performed targeted proteomic profiling to identify circulating endothelial‐associated proteins as ...
Rohit Benjamin +11 more
wiley +1 more source
The traditional immunology course mainly involves lectures and activities outside of the lectures, which prevents any links between basic knowledge and clinical practice.
Rasa Sepasi +3 more
doaj +1 more source
B cell apoptosis in systemic lupus erythematosus
link_to_subscribed_fulltextThe AAAAI 56th Annual Meeting, San Diego, California, 3-8 March 2000. In Journal of Allergy and Clinical Immunology, 2000, v. 105 n. 1 pt. 2, p.
Wu, A, Lau, CS, Chan, A, Chik, S
core +1 more source
Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui +10 more
wiley +1 more source
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu +10 more
wiley +1 more source

